Find a Study Now
Welcome to the future of
clinical research recruitment

Receive The Newest Study Notifications

Text
Select Page

First Patient in CytoDyn’s Triple-Negative Metastatic Breast Cancer Trial Shows Significant Reduction in Circulating Tumor Cells (CTC) and Reduced Tumor Size

by | Nov 12, 2019 | Study Scavenger Clinical Trial Recruitment Platform

VANCOUVER, Washington, Nov. 11, 2019 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic...

NextCure Presents Updated Clinical Data from NC318 Phase 1/2 Clinical Trial at the 34th Annual Meeting of Society for Immunotherapy of Cancer (SITC) and Announces Initiation of Phase 2 Portion of the Trial

by | Nov 11, 2019 | Study Scavenger Clinical Trial Recruitment Platform

NC318 was well tolerated Single agent activity observed in multiple tumor types, including a CR and a PR in NSCLC Initiated Phase 2 portion of the Phase 1/2 monotherapy trial and plans for a combo trial with standard of care chemotherapies BELTSVILLE, Md., Nov. 09,...

Kadimastem to Present Interim Results of Cohort A of Its Phase 1/2a Clinical Trial in ALS at the 7th International Stem Cell Meeting, in Tel-Aviv, Israel

by | Nov 11, 2019 | Study Scavenger Clinical Trial Recruitment Platform

Previously announced interim results demonstrated reduced disease progression in the first 3 months post-treatment period with AstroRx® NESS ZIONA, Israel, Nov. 11, 2019 /PRNewswire/ — Kadimastem Ltd. (KDST.TA), a clinical stage cell therapy company, today...
SEARCH FOR STUDIES